multi-target
Novartis and Schrödinger Forge $150M Drug Discovery Partnership with Billions in Potential Milestones
Novartis, Schrödinger, drug discovery pact, $150M upfront payment, multiyear collaboration, multi-target agreement.
Revolutionizing Drug Discovery: The Evolution from Target-Selective Design to AI-Powered Polypharmacology
Drug Discovery, Target-Selective Design, AI-Enabled Polypharmacology, Machine Learning, Systems Biology, Multi-Target Drugs, Personalized Medicine.